Paper
0
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Authors
Roxana Mehran,Usman Baber
Samin Sharma,David Cohen,Dominick Angiolillo,Carlo Briguori,Yichao Jin,Timothy Collier,George Dangas,Dariusz Dudek,Vladimír Džavík,Javier Escaned,Robert Gil,Paul Gurbel,Christian Hamm,Timothy Henry,Kurt Huber,Adnan Kastrati,Upendra Kaul,Ran Kornowski,Mitchell Krucoff,Vijay Kunadian,Steven Marx,Shamir Mehta,David Moliterno,E. Ohman,Keith Oldroyd,Gennaro Sardella,Samantha Sartori,Richard Shlofmitz,Philippe Steg,Giora Weisz,Bernhard Witzenbichler,Yaling Han,Stuart Pocock
+33 authors
,C. GibsonPublished
Sep 26, 2019
Show more
Save
Tip0
TipSave
Abstract
Monotherapy with a P2Y12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI).
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.